The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
Dopamine-loaded blood exosomes targeted to brain for better treatment of Parkinson’s disease
Abstract
Parkinson's disease (PD), one of the most common movement and neurodegenerative disorders, is challenging to treat, largely because the blood-brain barrier blocks passage of most drugs. Here we find exosomes from blood showing natural brain targeting ability which involved the transferrin-transferrin receptor interaction. Thus, we develop a biocompatible platform based on blood exosomes for delivering drugs across the blood-brain barrier. Blood exosomes show sizes between 40 and 200 nm and spherical morphology, and dopamine can be efficiently loaded into blood exosomes by a saturated solution incubation method. Further in vitro and in vivo studies demonstrates these exosomes successfully delivered dopamine to brain, including the striatum and substantia nigra. Brain distribution of dopamine increased >15-fold by using the blood exosomes as delivery system. Dopamine-loaded exosomes show much better therapeutic efficacy in a PD mouse model and lower systemic toxicity than free dopamine after intravenous administration. These results suggest that blood exosomes can be used as a promising drug delivery platform for targeted therapy against PD and other diseases of the central nervous system.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In a mouse Parkinson’s disease (PD) model, exosomes with pre-loaded dopamine exhibited better performance than free dopamine after intravenous injection [74].”
From The Therapeutic Potential and Clinical Significance of Exosomes as Carriers of Drug Delivery System (2022) · cites this paper as [74]
Citations
Cites
Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes
Alvarez-Erviti, L., Seow, Y., Yin, H., Betts, C., Lakhal, S., & Wood, M. J. A. (2011) · Nature Biotechnology · doi:10.1038/nbt.1807 · Cited by 4,930
Regulated portals of entry into the cell
Conner, S. D., & Schmid, S. L. (2003) · Nature · doi:10.1038/nature01451 · Cited by 3,959
Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET
Peinado, H., Alečković, M., Lavotshkin, S., Matei, I., Costa-Silva, B., Moreno-Bueno, G., Hergueta-Redondo, M., Williams, C., García-Santos, G., Ghajar, C. M., et al. (2012) · Nature Medicine · doi:10.1038/nm.2753 · Cited by 3,715
Pan, B., & Johnstone, R. M. (1983) · Cell · doi:10.1016/0092-8674(83)90040-5 · Cited by 2,042
Tian, Y., Li, S., Song, J., Ji, T., Zhu, M., Anderson, G. J., Wei, J., & Nie, G. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2013.11.083 · Cited by 1,841
Molecular Pathways of Neurodegeneration in Parkinson's Disease
Dawson, T. M., & Dawson, V. L. (2003) · Science · doi:10.1126/science.1087753 · Cited by 1,674
Systemically Injected Exosomes Targeted to EGFR Deliver Antitumor MicroRNA to Breast Cancer Cells
Ohno, S.-I., Takanashi, M., Sudo, K., Ueda, S., Ishikawa, A., Matsuyama, N., Fujita, K., Mizutani, T., Ohgi, T., Ochiya, T., et al. (2013) · Molecular Therapy · doi:10.1038/mt.2012.180 · Cited by 1,666
Sun, D., Zhuang, X., Xiang, X., Liu, Y., Zhang, S., Liu, C., Barnes, S., Grizzle, W. E., Miller, D., & Zhang, H. (2010) · Molecular Therapy · doi:10.1038/mt.2010.105 · Cited by 1,579
Development of exosome-encapsulated paclitaxel to overcome MDR in cancer cells
Kim, M. S., Haney, M. J., Zhao, Y., Mahajan, V., Deygen, I., Klyachko, N. L., Inskoe, E., Piroyan, A., Sokolsky, M., Okolie, O., et al. (2016) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2015.10.012 · Cited by 1,410
Zhuang, X., Xiang, X., Grizzle, W., Sun, D., Zhang, S., Axtell, R. C., Ju, S., Mu, J., Zhang, L., Steinman, L., et al. (2011) · Molecular Therapy · doi:10.1038/mt.2011.164 · Cited by 1,356
Self-citation
Flagged first, then by citations
Cited by
Sorted by citations
Items 401–500 of 543
Zhang, C., Liu, Y., Bai, T., Shao, H., Xiong, Z., Epstein, M. M., Li, X., & Chen, H. (2025) · Biotechnology Advances · doi:10.1016/j.biotechadv.2025.108637 · Cited by 9
Liu, X.-Q. N., & Sheng, R. N. (2025) · Journal of Integrative Neuroscience · doi:10.31083/jin47443 · Cited by 9
Exosomes: A Cellular Communication Medium That Has Multiple Effects On Brain Diseases
Fang, X., Zhou, D., Wang, X., Ma, Y., Zhong, G., Jing, S., Huang, S., & Wang, Q. (2024) · Molecular Neurobiology · doi:10.1007/s12035-024-03957-4 · Cited by 7
Idowu, O. K., Dosumu, O. O., Boboye, A. S., Oremosu, A. A., & Mohammed, A. A. (2024) · Brain and Behavior · doi:10.1002/brb3.70001 · Cited by 7
Bioengineering extracellular vesicles as novel nanocarriers towards brain disorders
Wu, J., Ma, L., Sun, D., Zhang, X., Cui, J., Du, Y., Guo, Y., Wang, X., Di, L., & Wang, R. (2022) · Nano Research · doi:10.1007/s12274-022-4913-2 · Cited by 8
Targeted transport of biotherapeutics at the blood-brain barrier
Moos, T., Thomsen, M. S., Burkhart, A., Hede, E., & Laczek, B. (2023) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2023.2292697 · Cited by 8
Zhang, K., Hu, J., & Hu, Y. (2024) · Extracellular Vesicle · doi:10.1016/j.vesic.2024.100061 · Cited by 6
The quest for Parkinson’s disease biomarkers: traditional and emerging multi-omics approaches
Sharma, P., & Dhamija, R. K. (2025) · Molecular Biology Reports · doi:10.1007/s11033-025-10929-x · Cited by 7
Potential of Exosomes as Multifunctional Nanocarriers for Targeted Drug Delivery
Al-Ani, S. A., Lee, Q. Y., Maheswaran, D., Sin, Y. M., Loh, J. S., Foo, J. B., Hamzah, S. B., Ng, J. F., & Tan, L. (2024) · Molecular Biotechnology · doi:10.1007/s12033-024-01268-6 · Cited by 6
Exploring the potential of MFG-E8 in neurodegenerative diseases
Li, D., Wang, R., Lu, W., & Ma, Y. (2024) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2024.2417800 · Cited by 8
Formulating and Characterizing an Exosome-based Dopamine Carrier System
Yavuz, B., Darıcı, H., Yildiz, A. P. Z., Abamor, E. Ş., Topuzoğulları, M., Bağırova, M., Allahverdiyev, A., & Karaöz, E. (2022) · Journal of Visualized Experiments · doi:10.3791/63624 · Cited by 8
Zhou, S., Zheng, X., Chen, J., Xu, Y., Du, X., Wang, C., Cui, P., Qiu, L., Jiang, P., Ni, X., et al. (2022) · Journal of Biomedical Nanotechnology · doi:10.1166/jbn.2022.3253 · Cited by 6
Biofluid-Derived Exosomal LncRNAs: Their Potential in Obesity and Related Comorbidities
Ngowi, E. E., Lu, T., Liu, Q., Xie, X., Wang, N., Luo, L., Deng, L., Zhou, Y., Zhang, Z., & Qiao, A. (2024) · Biology · doi:10.3390/biology13120976 · Cited by 5
Self-citationInnovative Lipid-Based Nanobiotechnology: Diagnostics and Medicine
Seo, S. E., Kim, K. H., Singh, S., Chen, J.-S., Iijima, S., Cheng, C., Ryu, Y., Song, H. S., Li, W., & Kwon, O. S. (2026) · ACS Nano · doi:10.1021/acsnano.5c16718 · Cited by 5
Exosomes as Emerging Nanocarriers for Targeted Cancer Therapy
Du, Y., Liu, D., Liu, J., Yu, J., Hao, Z., Zhang, M., Li, J. W., & Peng, X. Y. (2026) · International Journal of Nanomedicine · doi:10.2147/ijn.s585042 · Cited by 5
Holghoomi, R., Rahdar, A., Kadkhoda, J., Mohammadzadeh, V., Shirzad, M., Salehi, B., Ebrahimi, M.-S., & Pandey, S. (2026) · Nano LIFE · doi:10.1142/s179398442630013x · Cited by 6
Biomacromolecule-tagged nanoscale constructs for crossing the blood–brain barrier
Odom, T. L., LeBroc, H. D., & Callmann, C. E. (2024) · Nanoscale · doi:10.1039/d3nr06154j · Cited by 5
Research progress on incomplete partition type 3 inner ear malformation
Xu, K., Xiao, Y., Luo, J., Chao, X., Wang, R., Fan, Z., Wang, H., & Xu, L. (2024) · European Archives of Oto-Rhino-Laryngology · doi:10.1007/s00405-024-08555-7 · Cited by 5
Abioye, A. O., Akintade, D. D., Mitchell, J., Olorode, S., & Adejare, A. (2024) · Pharmaceutics · doi:10.3390/pharmaceutics16050609 · Cited by 7
Singh, J. P., Saini, G., Singh, B., & Tiwari, G. (2024) · Pharmaceutical Nanotechnology · doi:10.2174/0122117385306281240427073651 · Cited by 5
Hu, C., Dai, S., Zhao, X., Tang, R., Shan, P., Yin, W., Li, P., Wang, S., Zhou, Q., & Qi, H. (2024) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.4c05160 · Cited by 5
Emerging role and translational potential of small extracellular vesicles in neuroscience
Shanmugam, I., Radhakrishnan, S., Santosh, S., Ramnath, A., Anil, M., Devarajan, Y., Maheswaran, S., Narayanan, V., & Pitchaimani, A. (2024) · Life Sciences · doi:10.1016/j.lfs.2024.122987 · Cited by 6
Recent trends of extracellular vesicles for therapeutic intervention of brain-related diseases
Handa, M., Reddy, G. A., Panicker, N., Singh, S., & Ruwali, M. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-85544-0.00007-1 · Cited by 5
Fan, B., Gu, J., Wu, J., Sun, Y., Huang, R., Shen, H., Zhang, X., & Li, Z. (2022) · Journal of Biomedical Nanotechnology · doi:10.1166/jbn.2022.3293 · Cited by 5
Goudarzi, F., Jajarmi, V., Shojaee, S., Mohebali, M., & Keshavarz, H. (2023) · Microbiology Spectrum · doi:10.1128/spectrum.03080-23 · Cited by 7
Zhaoyan, 杨. Y., Shujin, 赵. Z., Ziye, 王. W., Jiao, 刘. L., Shenfei, 宗. Z., Zhuyuan, 王. W., Bingxiang, 李. L., & Yiping, 崔. C. (2023) · Acta Optica Sinica · doi:10.3788/aos230823 · Cited by 5
Extracellular Vesicles: The Invisible Heroes and Villains of COVID‐19 Central Neuropathology
Chang, H., Chen, E., Hu, Y., Wu, L., Deng, L., Ye, S., Mao, X., Zhu, T., Liu, J., & Chen, C. (2023) · Advanced Science · doi:10.1002/advs.202305554 · Cited by 4
Frontiers of Neurodegenerative Disease Treatment: Targeting Immune Cells in Brain Border Regions
Satyanarayanan, S. K., Han, Z., Xiao, J., Yuan, Q., Yung, W., Ke, Y., Chang, R. C., Zhu, M. H., Su, H., Su, K. P., et al. (2024) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2024.10.007 · Cited by 5
Kajitani, G. S., Xavier, G., Villena-Rueda, B. E., Karia, B. T. R., & Santoro, M. L. (2024) · Current topics in membranes · doi:10.1016/bs.ctm.2024.06.002 · Cited by 4
Boyton, I., Rennie, C., Collins‐Praino, L. E., & Care, A. (2024) · ChemNanoMat · doi:10.1002/cnma.202400147 · Cited by 4
Işık, M., Sari, H. K., Çağlayan, M. G., Yılmaz, R., & Derkuş, B. (2025) · European Journal of Neuroscience · doi:10.1111/ejn.70090 · Cited by 4
Therapeutic potential of extracellular vesicle-polyphenol nanoplatform in regenerative medicine
Ma, M., Wu, Q., Wang, T., Ma, Y., Le, F., Wang, Y., Jiang, L., Gu, Z., & Hao, Z. (2025) · Nano Materials Science · doi:10.1016/j.nanoms.2025.05.008 · Cited by 5
Unveiling Exosome Potential: Transforming Treatments for Neurodegeneration
Tiwari, A. K., Singh, B. K., Singh, G. K., Meena, J., Agrawal, A. K., Kumar, S., & Modi, G. P. (2025) · ACS Applied Bio Materials · doi:10.1021/acsabm.5c00096 · Cited by 4
Wang, J., Chen, J., Chen, J., Xia, K., Yuan, P., Zhou, X., Wang, R., Yu, C., Li, Y., Shi, K., et al. (2025) · ACS Nano · doi:10.1021/acsnano.5c08255 · Cited by 4
Chakravarty, S., Revi, N., & Bijukumar, D. R. (2026) · Biomedical Materials · doi:10.1088/1748-605x/ae6164 · Cited by 4
U6/miR-211 expression ratio as a purity parameter for HEK293 cell-derived exosomes
Kluszczyńska, K., Pęczek, Ł., Różański, A., Czernek, L., & Duechler, M. (2022) · Acta Biochimica Polonica · doi:10.18388/abp.2020_5870 · Cited by 4
Schulze, T. G., & Delalle, I. (2022) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2022.07.007 · Cited by 4
Colorimetric Assaying of Exosomal Metabolic Biomarkers
Yan, E., Goyal, G., Yıldız, Ü. H., Boehm, B. O., & Palaniappan, A. (2023) · Molecules · doi:10.3390/molecules28041909 · Cited by 4
Exploring exosomes to provide evidence for the treatment and prediction of Alzheimer’s disease
QUAN, X., MA, X., LI, G., FU, X., LI, J., & ZENG, L. (2023) · Biocell · doi:10.32604/biocell.2023.031226 · Cited by 4
Yavuz, B., Yildiz, A. P. Z., Abamor, E. Ş., Darıcı, H., & Allahverdiyev, A. (2023) · Regenerative Engineering and Translational Medicine · doi:10.1007/s40883-023-00322-0 · Cited by 4
Wang, J., Wang, D., Setrerrahmane, S., Martínez, J., & Xu, H. (2023) · Aging · doi:10.18632/aging.205150 · Cited by 4
Lu, D., Sun, H., Fan, H., Li, N., Li, Y., Yin, X., Fan, Y., Sun, H., Wang, S., & Xin, T. (2024) · Neuroscience · doi:10.1016/j.neuroscience.2024.11.011 · Cited by 4
FMR1 Disorders: Basics of Biology and Therapeutics in Development
Gillett, D. A., Tigro, H., Wang, Y., & Suo, Z. (2024) · Cells · doi:10.3390/cells13242100 · Cited by 4
Recent advances in biomimetic nanodelivery systems for the treatment of glioblastoma
Yuan, Z., Li, J., & Na, Q. (2025) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2025.114668 · Cited by 5
Zhu, L., Li, L., Lin, X.-Y., Hu, J., Wang, C., Wang, Y.-J., Zhou, Q., & Zhang, J. (2025) · Molecular Neurobiology · doi:10.1007/s12035-025-04948-9 · Cited by 6
Role of Exosomes in the Treatment of Diseases
Mirzaei, H., Rahimian, N., Mirzaei, H. R., Nahand, J. S., & Hamblin, M. R. (2022) · Synthesis lectures on biomedical engineering · doi:10.1007/978-3-031-79177-2_8 · Cited by 4
Research Progress of Extracellular Vesicles Targeted Therapy
Chen, Y., & Hou, S. (2023) · Advanced Therapeutics · doi:10.1002/adtp.202200255 · Cited by 4
Rac GTPase activating protein 1 promotes the glioma growth by regulating the expression of MCM3
Jia, B., Jiang, Y., Yu, H., Han, Y., Liu, W., Liu, X., Wang, Y., He, L., Cao, Z., He, X., et al. (2023) · Translational Oncology · doi:10.1016/j.tranon.2023.101756 · Cited by 4
Biomaterials and Stem Cells as Drug/Gene-Delivery Vehicles for Parkinson’s Treatment: An Update
Roshani, M., Kiaie, N., & Aghdam, R. M. (2021) · Regenerative Medicine · doi:10.2217/rme-2021-0050 · Cited by 4
Inorganic Nanoparticles-based Drug Delivery Systems for Neurodegenerative Diseases Therapy
Bagherpour, I., Mozafari, M. R., & Naghib, S. M. (2025) · Current Pharmaceutical Design · doi:10.2174/0113816128352935250116064725 · Cited by 5
Fu, J., Huang, S., Zhang, A., Shi, R., Wei, Y., He, S., Huang, S., Li, L., Sun, X., Gong, T., et al. (2025) · Journal of Pharmaceutical Analysis · doi:10.1016/j.jpha.2025.101413 · Cited by 4
Self-citationFang, J., Qin, F., Pengcheng, X., Zhao, X., Zhang, Z., Xia, D., Liu, J., Yu, J., Hu, L., Wang, Y., et al. (2025) · Brain and Behavior · doi:10.1002/brb3.70966 · Cited by 3
Self-citationPandey, S., Dwivedi, A., Singh, R., Habib, N., Kashyap, D., Saini, V., Singh, A., Sharma, A., & Jha, H. C. (2025) · Human Gene · doi:10.1016/j.humgen.2025.201507 · Cited by 5
Deshetty, U. M., Singh, S., Martínez-Cuevas, F. L., Jain, S., Buch, S. J., & Periyasamy, P. (2026) · Immuno · doi:10.3390/immuno6010012 · Cited by 5
Extracellular Vesicles in Alzheimer’s Disease: Mechanisms, Biomarkers, and Therapeutic Engineering
Wang, L., Mao, L., & Zong, X. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27093974 · Cited by 4
Self-citationExosomes as a Future Diagnostic Tool for Brain Disorders
Bhawale, R., Vasave, R., & Mehra, N. K. (2024) · Springer eBooks · doi:10.1007/978-981-99-8373-5_14 · Cited by 3
Zhou, J., Pu, Y., Ren, X., Li, L., Chen, Z., Lo, E. H., & Li, W. (2025) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x251348816 · Cited by 3
Su, W., Du, Y., Wang, W., Li, Q., Zhang, J., & He, W. (2025) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2025.119322 · Cited by 4
Exosomes: Novel Bio-Inspired Nanocarriers for Efficient Targeting of Glioblastoma Tumor Cells
Nooshabadi, V. T., Arab, S., & Taghdiri-Nooshabadi, Z. (2021) · DOAJ (DOAJ: Directory of Open Access Journals) · Cited by 3
Physiologic constraints of using exosomes in vivo as systemic delivery vehicles
Lee, D. S., Suh, M., Kang, S. Y., & Hwang, D. W. (2019) · Precision Nanomedicine · doi:10.33218/prnano2(3)070819.1 · Cited by 3
Zhang, Z., Zhao, W. G., Gu, P., Zhou, Y., Wu, R., Zhou, L., Cui, Q., Chen, H., Zhang, L., Zhang, K., et al. (2022) · Research Square · doi:10.21203/rs.3.rs-1663711/v1 · Cited by 3
Self-citationBlachier, F. (2023) · Springer eBooks · doi:10.1007/978-3-031-26322-4_5 · Cited by 2
Treatment and early diagnosis of Parkinson's disease: Opportunities of nanotechnology
Kong, J., Chu, R., Ma, S., & Wang, Y. (2025) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2025.216959 · Cited by 4
Exosomes as Emerging Therapeutic Platforms in Neurological and Psychiatric Disorders
Kumar, R. M. R., Logesh, R., & Chidambaram, S. B. (2025) · Pharmaceutical Medicine · doi:10.1007/s40290-025-00584-9 · Cited by 4
Hu, S., Deng, L., Cai, Z. P., Yuan, Q., Jiang, L., Luo, C., Wang, Y., & Huang, Y. (2025) · Behavioural Brain Research · doi:10.1016/j.bbr.2025.115917 · Cited by 2
Extracellular vesicles in neurological disorders: emerging roles and underlying molecular mechanisms
Mimi, M. A., & Hasan, M. M. (2025) · Exploration of neuroscience · doi:10.37349/en.2025.1006118 · Cited by 2
RetractedChen, Z., Wang, Z., Yang, M., Yan, R., Lv, L., Chang, Y., Chen, K., Wenjiang, Y., Yuan, H., Meng, X., et al. (2026) · Nanoscale · doi:10.1039/d5nr04823k · Cited by 2
Nguyen, T. H., Huynh, N. T., Niego, B., Hagemeyer, C. E., & Xu, R. (2026) · Small Structures · doi:10.1002/sstr.202500709 · Cited by 2
Castegna, A., Laera, L., Moda, P., Miglietta, S., D’Agostino, M., Ruggiero, M., Cianciulli, A., Filannino, F. M., Porro, C., Butterfield, D. A., et al. (2026) · Journal of Translational Medicine · doi:10.1186/s12967-026-08102-4 · Cited by 3
Prodromos, C. C., Villar, R. D., Striegel, A., Pena, G. R., & Dixit, R. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27104483 · Cited by 2
The Roads We Take: Cellular Targets and Pathways Leading Biologics Across the Blood–Brain Barrier
Baghirov, H. (2022) · Frontiers in Drug Delivery · doi:10.3389/fddev.2022.946045 · Cited by 2
Khan, J., & Tatlı, I. İ. (2023) · Springer eBooks · doi:10.1007/978-981-99-3848-3_8 · Cited by 2
Ali, S., Mukherjee, S., Goel, D., Ghosh, A., & Faruq, M. (2023) · Springer eBooks · doi:10.1007/978-981-99-3848-3_10 · Cited by 2
Ahmadi, S. A., & Tajik, S. (2023) · Topics in Catalysis · doi:10.1007/s11244-023-01866-9 · Cited by 2
Novel Metabolic Biomarkers and Therapeutic Strategies in Neurodegenerative Diseases
Thapliyal, A., Shweta, & Maurya, S. K. (2024) · Springer eBooks · doi:10.1007/978-981-97-4288-2_14 · Cited by 2
Exosomes as nanocarrier for Neurotherapy: Journey from application to challenges
Ale, Y., & Nainwal, N. (2024) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2024.106312 · Cited by 2
Exosomes: Future Perspective in Neurodegenerative Diseases
Alidoust, L., & Jafari, A. (2020) · Caspian Journal of Neurological Sciences · doi:10.32598/cjns.6.23.4 · Cited by 1
Extracellular Vesicles: The Challenges on the Way and Engineering Perspectives
Attia, N., Ibrahim, H. G., Abdulla, H., Mashal, M., Puras, G., & Pedraz, J. L. (2024) · Springer eBooks · doi:10.1007/978-981-99-7119-0_56 · Cited by 1
She, P., Ao, X., Zhan, X., Zhou, W., Cheng, Y., Yang, H. J., Wu, S., Zhang, X., Peng, W., & Wang, J. (2024) · BME Horizon · doi:10.70401/bmeh.2024.124 · Cited by 2
Recent advances on the role of exosomes in neurodegenerative diseases
Bu, C.-T., Zhu, X., Zhang, Q., & Wenya, S. H. A. O. (2025) · Chinese Journal of Chromatography · doi:10.3724/sp.j.1123.2024.10035 · Cited by 1
Li, Z. J., Yang, S., & Su, L. (2025) · Pharmaceutics · doi:10.3390/pharmaceutics17091175 · Cited by 1
Self-citationLin, W., Qian, Y., Jiang, S., Zhou, H., & Chen, G. (2025) · Brain Network Disorders · doi:10.1016/j.bnd.2025.09.001 · Cited by 1
Exosomal Cargoes Derived from Neural Stem Cell: A New Strategy of Parkinson's Disease Treatment
Tarbali, S., Dadkhah, M., & Payandeh, Z. (2026) · Molecular Neurobiology · doi:10.1007/s12035-025-05637-3 · Cited by 2
Exosomes for brain drug delivery: The cutting edge in nanomedicine
Ghaedi, A., Saem, A., Bazrgar, A., Dowran, R., Mallahi, A., Zarimeidani, F., Rahmati, R., Shahvandi, E., Goodarzian, M., Vakili, S., et al. (2026) · Experimental Neurology · doi:10.1016/j.expneurol.2026.115692 · Cited by 2
Advanced small extracellular vesicles delivery systems for in situ tissue engineering
Gao, Y., Sang, J., Wan, Z., Wang, Y., Yuan, X., Dong, Y., Yuan, Z., & Zhao, Y. (2026) · Extracellular Vesicles and Circulating Nucleic Acids · doi:10.20517/evcna.2025.149 · Cited by 1
Fu, Z., Kuang, Y., Li, M., Zhou, K., Shi, H., Gu, Y., Wu, X., Zhu, Y., & Liu, J. (2026) · Extracellular Vesicles and Circulating Nucleic Acids · doi:10.20517/evcna.2025.184 · Cited by 1
Stein, J. B., Arif, M., Cheung, H., & Lee, K. (2026) · Cell Biomaterials · doi:10.1016/j.celbio.2026.100495 · Cited by 2
Khan, N. H., Bushra, M. A., Selina, F. A., & Arbab, A. S. (2026) · Cancers · doi:10.3390/cancers18121923 · Cited by 3
Liu, Y., Yao, Z., Zhu, L., & Peng, W. (2026) · Journal of Nanobiotechnology · doi:10.1186/s12951-026-04705-7 · Cited by 1
Brain energy crisis in Alzheimer’s and Parkinson’s disease: Nanotechnology as a therapeutic strategy
Milmile, M., Singh, S., Pandey, A., Pawar, G., Petkar, P., Chander, Y., Mishra, R., & Chawla, R. (2026) · International review of neurobiology · doi:10.1016/bs.irn.2026.05.016 · Cited by 1
Mac, C., Chiang, Y., Nguyen, H., Wang, J., Chu, L., Lin, Y., Khánh, N. V., Peng, S., Lo, S., Chang, Y., et al. (2026) · Advanced Materials · doi:10.1002/adma.74148 · Cited by 1
Ghosh, S. B., Banerjee, R., Almohaimeed, H. M., Almars, . I., ALMatrafi, T. A., Saleh, F. M., Mohammedsaleh, Z. M., Ealla, K. K. R., Kumer, A., & Dhara, B. (2026) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.71297 · Cited by 1
Xu, K., Kou, D., Xiao, X., Bai, B., Liu, C., Wu, M., Shi, Y., Xu, M., Cao, X., Qi, H., et al. (2026) · Advanced Science · doi:10.1002/advs.77025 · Cited by 1
Al‐allaq, A. A., Hassan, H. A., Hidayet, H. M., Abdulhakeem, A. A., & Ahmad, Z. A.-A. Q. (2026) · Micro · doi:10.3390/micro6030065 · Cited by 1
Biological nanodrugs for brain targeting
Jovčevska, I. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-90773-6.00028-2 · Cited by 1
Yang, Z., Zong, S., Jiang, G., Zhu, K., Qian, Z., Yang, K., Wang, Z., & Cui, Y. (2023) · Analytical Methods · doi:10.1039/d2ay01855a · Cited by 1
Theranostic Applications of Functionalized Exosomes
Waheed, A., Ahad, A., Gupta, D. K., Ali, A., Aqil, M., Sultana, Y., Al-Jenoobi, F. I., & Al-Mohizea, A. M. (2023) · Springer eBooks · doi:10.1007/978-981-99-0538-6_12 · Cited by 1
Engineered Exosomes as Nano-Vectors against Neurodegenerative Disorders
Muteeb, G., Zia, Q., & Alshoaibi, A. A. (2023) · Springer eBooks · doi:10.1007/978-981-99-3848-3_12 · Cited by 1
A biointegrated living brain stimulator evokes specific neural signallingPreprint
Zhao, Q., Meng, Q., Peng, M., Lu, Z., Liu, Z. H., Jiang, X., Zheng, H., & Du, X. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.05.22.725279 · Cited by 1
Research Advances in Exosome and Their MicroRNA for Parkinson’s Disease
白, 家. (2019) · Advances in Clinical Medicine · doi:10.12677/acm.2019.95098
Metadata
- Authors
- Qu, M., Lin, Q., Huang, L., Fu, Y., Wang, L., He, S., Fu, Y., Yang, S., Zhang, Z., Zhang, L., & Sun, X.
- Affiliations
- Sichuan University (CN)
- Corresponding author
- Zhang, Ling
- Sun, Xun
- ORCID
- Venue
- Journal of Controlled Release
- Publisher
- Elsevier BV
- Published
- 2018-10
- Volume
- 287
- Pages
- 156-166
- ISSN
- 0168-3659 (ISSN-L)
- OpenAlex
- W2888790211
- Cited by
- 543
- References
- 43
- Citations by year
- 2026: 44 · 2025: 72 · 2024: 106 · 2023: 99 · 2022: 81 · 2021: 63 · 2020: 48 · 2019: 27 · 2018: 3
- FWCI
- 12.54
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Controlled Release (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Graduate Student's Research and Innovation Fund of Sichuan University
- National Natural Science Foundation of China (81690261)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Extracellular vesicles in disease
- Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
- Life Sciences › Neuroscience › Neurology › Barrier Structure and Function Studies
- Keywords
- Parkinson's disease, blood exosomes, blood-brain barrier, transferrin receptor, brain targeting, striatum, substantia nigra, brain drug delivery, neurodegenerative disease treatment
- MeSH terms
- Animals, Brain, Dopamine, Drug Carriers, Parkinson Disease, Dopamine Agents, Drug Delivery Systems, Mice, Exosomes
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
